from the United States Court of Appeals for the Federal Circuit
See other cases from the Federal Circuit.
The Solicitor General is invited to file a brief in this case expressing the views of the United States.
Reply of petitioner RPX Corporation filed. (Distributed)
Brief of respondent Chanbond LLC in opposition filed.
Response Requested. (Due August 24, 2018)
Brief amicus curiae of The Initiative for Medicines Access & Knowledge (I-Mak) and Patients for Affordable Drugs, Inc. (P4AD) filed. (Distributed)
Brief amicus curiae of New York Intellectual Property Law Association in support of neither party filed. (Distributed)
Letter of June 28, 2018, received from counsel for the petitioner.
Petition for a writ of certiorari filed. (Response due July 20, 2018)
Application (17A1057) granted by The Chief Justice extending the time to file until June 16, 2018.
Application (17A1057) to extend the time to file a petition for a writ of certiorari from April 17, 2018 to June 16, 2018, submitted to The Chief Justice.
RPX Corporation, Petitioner, represented by Daniel B. Ravicher
Chanbond LLC, Respondent, represented by Andrea Pacelli
The Initiative for Medicines Access & Knowledge (I-Mak) and Patients for Affordable Drugs, Inc. (P4AD), Amicus Curiae, represented by Aditya Neal Seth